This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Universal Health (UHS) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Universal Health's (UHS) second-quarter earnings are likely to be boosted by solid revenue growth. However, increasing cost of debt might hurt the bottom line.
UnitedHealth (UNH) Beats on Q2 Earnings, Guides Up for 2017
by Zacks Equity Research
Higher revenues, strength in UnitedHealthcare and Optum segments and membership growth drive earnings beat at UnitedHealth Group Inc. (UNH) in Q2.
Visa (V) Gearing Up for Q3 Earnings: Is a Surprise in Store?
by Zacks Equity Research
We expect fiscal third-quarter earnings of Visa Inc. (V) to gain traction from its digital initiatives.
UnitedHealth Faces Moody's Rating Action, Outlook Upgraded
by Zacks Equity Research
UnitedHealth (UNH) rating action by Moody's takes into account the company's its leadership position in the industry, its diversified business product profile.
UnitedHealth (UNH) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Our proven model does not conclusively show that UnitedHealth (UNH) is likely to beat on earnings this quarter.
Cigna (CI) Hits 52-Week High on Recent Buyout, Growth Plans
by Zacks Equity Research
The stock of Cigna (CI) hit a 52-week high of $173.44. The rise in the stock is believed to have been driven by an acquisition, its detailed long-term growth plans.
Aetna to Shift Headquarters, Aims Business Transformation
by Zacks Equity Research
Aetna Inc. (AET) will move out of its Hartford, to look for "younger people, technologists, innovation" as it transforms into a digital health entity.
Buy these 5 Low Leverage Stocks to Withstand Market Downturn
by Zacks Equity Research
It is wiser to look for low-leveraged stocks that are financially more secure and thus less susceptible to market upheavals.
Walgreens (WBA) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) is slated to release third-quarter fiscal 2017 results before the market opens on Jun 29.
Aetna Inks New Deal to Improve Healthcare in North Carolina
by Zacks Equity Research
Aetna, Inc. (AET) recently inked a deal with Community Care Physician Network, LLC
Senate Releases AHCA Draft Bill, Healthcare Stocks Surge
by Zacks Equity Research
The Senate recently released the draft version of the healthcare bill that would repeal and replace the Affordable Care Act.
Anthem Quits 2 More Exchanges Amid Regulatory Uncertainty
by Zacks Equity Research
Anthem Inc. (ANTM) is quitting public exchange markets in the states of Wisconsin and Indiana for 2018.
3 Value Stocks in Health Insurance Promising Solid Returns
by Zacks Equity Research
The health insurance industry is continuing its steady ride despite significant pullbacks. Players in the industry remain poised to grow on ever-increasing demand for government plans.
Buy these 5 Low Leverage Stocks as Market Hits Record High
by Zacks Equity Research
Since volatility can hit the global markets any time, it is wise to choose less risky stocks. Companies with a lower level of debt are considered safe bets.
UnitedHealth (UNH) Announces 20% Dividend Hike, Stock Gains
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) has once again cheered its investors by instituting a quarterly dividend hike of 20%.
Here's Why You Should Bet on Humana (HUM) Stock Right Now
by Zacks Equity Research
Louisville-based Humana Inc. (HUM), one of the largest health care plan providers in the United States, has been an investor favorite, given its strong fundamentals
4 Reasons to Stay Away from Mednax (MD) Now
by Zacks Equity Research
Mednax (MD) is suffering from subdued pace of birth across the country, which has slowed the growth of one of its core businesses, neonatology.
Humana (HUM) Up 2.7% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Hits 52-Week High on Strong Results, Client Wins
by Zacks Equity Research
Teladoc's (TDOC) 52-week high is believed to have been driven by the company's better-than-expected first-quarter earnings along with the recent news of expansion of its telehealth offerings in Texas.
Top Stock Reports for Eli Lily, HSBC, Marriott & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly (LLY), HSBC (HSBC) and Marriott (MAR).
Buy these 5 Low Leverage Stocks to Keep your Portfolio Safe
by Zacks Equity Research
The U.S. stock market recovered last Friday, driven by positive market sentiment with two significant data points for the month of May expected shortly. The consumer confidence figures will be released today while the jobs report is due on Friday.
UnitedHealth's (UNH) Business Unit Collaborates with Merck
by Zacks Equity Research
UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).
The Zacks Analyst Blog Highlights: Humana, UnitedHealth Group, Tenet Healthcare, LifePoint Health and Community Health Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Humana, UnitedHealth Group, Tenet Healthcare, LifePoint Health and Community Health Systems
Insurers & Hospital Stocks in Focus on CBO Report on Trumpcare
by Arpita Dutt
According to the CBO, 23M people would lose health coverage in 2026 under Trumpcare while federal deficits would go down by $119B over the coming decade.
New Stock Research Reports for Merck, 3M and United Technologies
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), 3M Co (MMM) and United Technologies Corporation (UTX).